Article

CK used for patients with LASIK, PRK complications

Conductive keratoplasty (CK) may afford a useful tool to correct optical complications of LASIK and PRK when further laser surgery is contraindicated, said Peter S. Hersh, MD, professor of ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

Chicago-Conductive keratoplasty (CK) may afford a useful tool to correct optical complications of LASIK and PRK when further laser surgery is contraindicated, said Peter S. Hersh, MD, professor of ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

CK is FDA-approved for correction of presbyopia and hyperopia; using it as a rescue procedure is an off-label application, Dr. Hersh said.

He provided results of a study in which he performed CK in 16 eyes of 15 patients who had LASIK and PRK complications and in whom further laser surgery or flap manipulation was inadvisable. Dr. Hersh performed 28 procedures; 8 eyes had CK twice, 1 eye 3 times, and 1 eye 4 times. The average number of spots was 15.

Uncorrected visual acuity averaged 20/68 preoperatively versus 20/37 postoperatively, while near UVCA improved from 20/102 to 20/39. Mean MRSE was +1.06 before surgery and –0.33 afterward. Best spectacle-corrected visual acuity remained unchanged in most eyes, averaging 20/23 before and after CK was performed.

Astigmatism results showed a change from 1.88 D preoperatively to 0.81 D postoperatively. Nine of 15 eyes improved >0.5 D, 5/15 were unchanged, and 1/15 was worse.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.